Systematic review / meta-analysis / 2017
Limited evidence suggests omega-3 fatty acid supplementation does not improve performance in children with autism spectrum disorder.
A systematic review and meta-analysis evaluated five RCTs with 183 children with autism spectrum disorder (ASD) comparing omega-3 fatty acid supplementation with placebo or no supplementation. With four exceptions, there were no significant differences in ASD symptoms between groups. Parents' ratings showed improved lethargy symptoms on the Aberrant Behavior Checklist (pooled MD: 1.98; 95% CI: 0.32, 3.63), but worsening of externalizing behavior (pooled MD: -6.22; 95% CI: -10.9, -1.59) and social skills (MD: -7; 95% CI: -13.62, -0.38) on the Behavioral Assessment System for Children. One trial reported improved daily-living scores on the Vineland Adaptive Behavior Scale (MD: 6.2; 95% CI: 0.37, 12.03). Firm conclusions could not be drawn due to the limited number of studies and small sample sizes.
- Study type
- Systematic review and meta-analysis of randomized controlled trials
- Who was studied
- 183 children diagnosed with autism spectrum disorder across 5 RCTs
- What was measured
- Autism spectrum disorder symptoms and functional outcomes measured by validated scales
THE PAPER
ω-3 Fatty Acid Supplementation Does Not Affect Autism Spectrum Disorder in Children: A Systematic Review and Meta-Analysis.
Horvath A, Łukasik J, Szajewska H. J Nutr, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.